Structure of the Ulster Strain Newcastle Disease Virus Hemagglutinin-Neuraminidase Reveals Auto-Inhibitory Interactions Associated with Low Virulence

Paramyxovirus hemagglutinin-neuraminidase (HN) plays roles in viral entry and maturation, including binding to sialic acid receptors, activation of the F protein to drive membrane fusion, and enabling virion release during virus budding. HN can thereby directly influence virulence and in a subset of avirulent Newcastle disease virus (NDV) strains, such as NDV Ulster, HN must be proteolytically activated to remove a C-terminal extension not found in other NDV HN proteins. Ulster HN is 616 amino acids long and the 45 amino acid C-terminal extension present in its precursor (HN0) form has to be cleaved to render HN biologically active. Here we show that Ulster HN contains an inter-subunit disulfide bond within the C-terminal extension at residue 596, which regulates HN activities and neuraminidase (NA) domain dimerization. We determined the crystal structure of the dimerized NA domain containing the C-terminal extension, which extends along the outside of the sialidase β-propeller domain and inserts C-terminal residues into the NA domain active site. The C-terminal extension also engages a secondary sialic acid binding site present in NDV HN proteins, which is located at the NA domain dimer interface, that most likely blocks its attachment function. These results clarify how the Ulster HN C-terminal residues lead to an auto-inhibited state of HN, the requirement for proteolytic activation of HN0 and associated reduced virulence.

[1]  I. Wilson,et al.  The Second Receptor Binding Site of the Globular Head of the Newcastle Disease Virus Hemagglutinin-Neuraminidase Activates the Stalk of Multiple Paramyxovirus Receptor Binding Proteins To Trigger Fusion , 2012, Journal of Virology.

[2]  P. Palese,et al.  Oncolytic Newcastle disease virus for cancer therapy: old challenges and new directions. , 2012, Future microbiology.

[3]  R. Lamb,et al.  Structure and Mutagenesis of the Parainfluenza Virus 5 Hemagglutinin-Neuraminidase Stalk Domain Reveals a Four-Helix Bundle and the Role of the Stalk in Fusion Promotion , 2011, Journal of Virology.

[4]  D. Alexander Newcastle disease in the European Union 2000 to 2009 , 2011, Avian pathology : journal of the W.V.P.A.

[5]  Role of the Two Sialic Acid Binding Sites on the Newcastle Disease Virus HN Protein in Triggering the Interaction with the F Protein Required for the Promotion of Fusion , 2011, Journal of Virology.

[6]  R. Lamb,et al.  Structure of the Newcastle disease virus hemagglutinin-neuraminidase (HN) ectodomain reveals a four-helix bundle stalk , 2011, Proceedings of the National Academy of Sciences.

[7]  D. Lavillette,et al.  Cell Entry of Enveloped Viruses , 2011, Advances in Genetics.

[8]  G. Taylor,et al.  N-Linked Glycan at Residue 523 of Human Parainfluenza Virus Type 3 Hemagglutinin-Neuraminidase Masks a Second Receptor-Binding Site , 2010, Journal of Virology.

[9]  R. Dutch,et al.  Viral entry mechanisms: the increasing diversity of paramyxovirus entry , 2009, The FEBS journal.

[10]  R. Lamb,et al.  Domain architecture and oligomerization properties of the paramyxovirus PIV 5 hemagglutinin-neuraminidase (HN) protein. , 2008, Virology.

[11]  R. Lamb,et al.  Structural basis of viral invasion: lessons from paramyxovirus F. , 2007, Current opinion in structural biology.

[12]  Weixian Lu,et al.  A time- and cost-efficient system for high-level protein production in mammalian cells. , 2006, Acta crystallographica. Section D, Biological crystallography.

[13]  T. Mettenleiter,et al.  Enhancement of Pathogenicity of Newcastle Disease Virus by Alteration of Specific Amino Acid Residues in the Surface Glycoproteins F and HN , 2006, Avian diseases.

[14]  Vanessa R. Melanson,et al.  Addition of N-Glycans in the Stalk of the Newcastle Disease Virus HN Protein Blocks Its Interaction with the F Protein and Prevents Fusion , 2006, Journal of Virology.

[15]  R. Lamb,et al.  Structural studies of the parainfluenza virus 5 hemagglutinin-neuraminidase tetramer in complex with its receptor, sialyllactose. , 2005, Structure.

[16]  B. Murphy,et al.  Recombinant Human Metapneumovirus Lacking the Small Hydrophobic SH and/or Attachment G Glycoprotein: Deletion of G Yields a Promising Vaccine Candidate , 2004, Journal of Virology.

[17]  G. Taylor,et al.  Biological Significance of the Second Receptor Binding Site of Newcastle Disease Virus Hemagglutinin-Neuraminidase Protein , 2004, Journal of Virology.

[18]  S. Elankumaran,et al.  The Hemagglutinin-Neuraminidase Protein of Newcastle Disease Virus Determines Tropism and Virulence , 2004, Journal of Virology.

[19]  G. Taylor,et al.  Second Sialic Acid Binding Site in Newcastle Disease Virus Hemagglutinin-Neuraminidase: Implications for Fusion , 2004, Journal of Virology.

[20]  M. Lawrence,et al.  Structure of the haemagglutinin-neuraminidase from human parainfluenza virus type III. , 2004, Journal of molecular biology.

[21]  T. Mettenleiter,et al.  Contribution of the length of the HN protein and the sequence of the F protein cleavage site to Newcastle disease virus pathogenicity. , 2003, The Journal of general virology.

[22]  R. Lamb,et al.  Influenza B virus BM2 protein is an oligomeric integral membrane protein expressed at the cell surface. , 2003, Virology.

[23]  S. Crennell,et al.  Crystal structure of the multifunctional paramyxovirus hemagglutinin-neuraminidase , 2001, Nature Structural Biology.

[24]  D J Alexander,et al.  Newcastle disease and other avian paramyxoviruses. , 2000, Revue scientifique et technique.

[25]  S. Crennell,et al.  Crystallization of Newcastle disease virus hemagglutinin-neuraminidase glycoprotein. , 2000, Virology.

[26]  S S Whitehead,et al.  Respiratory syncytial virus (RSV) SH and G proteins are not essential for viral replication in vitro: clinical evaluation and molecular characterization of a cold-passaged, attenuated RSV subgroup B mutant. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[27]  G. Murshudov,et al.  Refinement of macromolecular structures by the maximum-likelihood method. , 1997, Acta crystallographica. Section D, Biological crystallography.

[28]  Collaborative Computational,et al.  The CCP4 suite: programs for protein crystallography. , 1994, Acta crystallographica. Section D, Biological crystallography.

[29]  Yamamura Ken-ichi,et al.  Efficient selection for high-expression transfectants with a novel eukaryotic vector , 1991 .

[30]  H. Niwa,et al.  Efficient selection for high-expression transfectants with a novel eukaryotic vector. , 1991, Gene.

[31]  R. Lamb,et al.  Conversion of a class II integral membrane protein into a soluble and efficiently secreted protein: multiple intracellular and extracellular oligomeric and conformational forms , 1990, The Journal of cell biology.

[32]  K. Kuma,et al.  Newcastle disease virus evolution. I. Multiple lineages defined by sequence variability of the hemagglutinin-neuraminidase gene. , 1989, Virology.

[33]  F. Corpet Multiple sequence alignment with hierarchical clustering. , 1988, Nucleic acids research.

[34]  J. Gorman,et al.  Characterization of the sites of proteolytic activation of Newcastle disease virus membrane glycoprotein precursors. , 1988, The Journal of biological chemistry.

[35]  N. Millar,et al.  Nucleotide sequence of the fusion and haemagglutinin-neuraminidase glycoprotein genes of Newcastle disease virus, strain Ulster: molecular basis for variations in pathogenicity between strains. , 1988, The Journal of general virology.

[36]  J. Sheehan,et al.  Quantitative basic residue requirements in the cleavage-activation site of the fusion glycoprotein as a determinant of virulence for Newcastle disease virus , 1988, Journal of virology.

[37]  S. Hattori,et al.  Nucleotide sequence of the hemagglutinin-neuraminidase gene of Newcastle disease virus avirulent strain D26: evidence for a longer coding region with a carboxyl terminal extension as compared to virulent strains. , 1987, Virus research.

[38]  M. Hamaguchi,et al.  Structural comparison of the cleavage-activation site of the fusion glycoprotein between virulent and avirulent strains of Newcastle disease virus. , 1987, Virology.

[39]  H. Klenk,et al.  Proteolytic activation of the haemagglutinin-neuraminidase of Newcastle disease virus involves loss of a glycopeptide. , 1980, The Journal of general virology.

[40]  H. Klenk,et al.  Activation of precursors to both glycoporteins of Newcastle disease virus by proteolytic cleavage. , 1977, Virology.

[41]  H. Klenk,et al.  Proteolytic cleavage of the viral glycoproteins and its significance for the virulence of Newcastle disease virus. , 1976, Virology.

[42]  J. Gorman,et al.  Pathotyping isolates of Newcastle disease virus using antipeptide antibodies to pathotype-specific regions of their fusion and hemagglutinin-neuraminidase proteins , 1999, Archives of Virology.

[43]  S J Wodak,et al.  SFCHECK: a unified set of procedures for evaluating the quality of macromolecular structure-factor data and their agreement with the atomic model. , 1999, Acta crystallographica. Section D, Biological crystallography.

[44]  Z. Otwinowski,et al.  Processing of X-ray diffraction data collected in oscillation mode. , 1997, Methods in enzymology.

[45]  A. Lamb Paramyxoviridae : The virus and their replication , 1996 .

[46]  R. Lamb,et al.  Orthomyxoviridae: The Viruses and Their Replication. , 1996 .

[47]  Randy J Read,et al.  Electronic Reprint Biological Crystallography Phenix: Building New Software for Automated Crystallographic Structure Determination Biological Crystallography Phenix: Building New Software for Automated Crystallographic Structure Determination , 2022 .